Aonong Group(SH:603363) Shang Hai Zheng Quan Bao·2025-03-17 18:52Core Viewpoint - Fujian Aonong Biotechnology Group Co., Ltd. has announced that some subsidiaries are experiencing financial difficulties, leading to overdue debts totaling approximately 98.76 million yuan, which accounts for 10.26% of the company's latest audited net assets [2][3]. Group 1: Debt Overdue Situation - Some subsidiaries of the company are unable to repay debts on time due to tight liquidity, with overdue debts totaling approximately 98.76 million yuan as of March 14, 2025 [2][3]. - Among the overdue bank debts, the amount guaranteed by the company and claimed by creditors in the restructuring process is approximately 56.28 million yuan [3]. - The overdue loans related to farmers from subsidiaries Guizhou Aoxin Wufeng Breeding Co., Ltd. and Guizhou Aonong Qihuan Animal Husbandry Co., Ltd. total approximately 39.50 million yuan, with due dates ranging from November 27, 2024, to March 14, 2025 [4]. Group 2: Impact on the Company and Response Measures - As of March 14, 2025, the total overdue debts of the company and its wholly-owned and controlling subsidiaries amount to approximately 549.29 million yuan, accounting for 57.04% of the latest audited net assets [5]. - The overdue debts will lead to a decline in the company's financing capabilities, increased financial costs, and potential impacts on certain business operations. The company may face risks such as litigation, arbitration, and bank account freezes due to overdue debts [5]. - The company plans to actively negotiate with creditors to resolve the debt issues [5].